Covid Frontline Journalistic Hero: Mary Beth Pfeiffer
50 views • 01/23/2022
You are not going to want to miss this episode. Today we interview the journalistic hero of Covid-19 early treatment success, Mary Beth Pfeiffer. Her website says it best "Public health officials have blocked safe, inexpensive drugs that could control Covid-19, including ivermectin, hydroxychloroquine, fluvoxamine and others. They have failed even to advise basic preventatives like Vitamin D3, C, zinc and quercetin. The overemphasis on vaccines must give way to early treatment." Mary Beth dives deep to tell the miraculous stories of Covid survivors who have been ripped from the jaws of death due to medical malpractice, along with the heartbreaking stories of families denied the opportunity to try proven, life saving treatments- like those created by Dr. Paul Marik and Pierre Kory: founders of the life saving FLCCC. Mary Beth Pfeiffer has been an award winning journalist and investigative reporter for the past three decades. She has a passion to dig into vital medical and social issues where others fear to tread. She is the author of Lyme: The First Epidemic of Climate Change and Crazy in America: The Hidden Tragedy of Our Criminalized Mentally Ill. The book is a critically acclaimed look at treatment of the mentally ill in prisons and jails in the United States. Read More:
Resistance Chicks
P.O. Box 107
Milford, OH 45150
E-mail: [email protected]
Web Page
Twitter: @Masfaith3
Link Tree: Telegram!
Follow here:
Clouthub: Resistance Chicks Channel 1620
Resistance Chicks LIVE Fridays On Brighteon.TV 6:00-7:00 PM ET
FREE email alerts of the most important BANNED videos in the world
Get FREE email alerts of the most important BANNED videos in the world that are usually blacklisted by YouTube, Facebook, Google, Twitter and Vimeo. Watch documentaries the techno-fascists don't want you to know even exist. Join the free Brighteon email newsletter. Unsubscribe at any time. 100% privacy protected.
Your privacy is protected. Subscription confirmation required.